Third Rock Ventures is a venture capital firm based in Boston, founded in 2007, which invests in biotechnology startups.
Third Rock Ventures is a venture capital firm headquartered in Boston, Massachusetts. The firm was established by Kevin Starr, Mark Levin, and Robert Tepper in 2007. As of July 2019, Third Rock Ventures is managing an active portfolio of 34 companies and has sold off its ownership in 57 companies. The firm specializes in funding companies at the early stage of development, in the field of biotechnology. Third Rock ventures provided venture capital to MyoKardia, a company which focuses on genetic heart diseases, that went public in 2015.